I hope you are having a wonderful holiday season, enjoying shopping for gifts, visiting with friends and family, and making great resolutions and promises for the New Year.
What have I been doing?
My vacation started about a week ago. But I don’t know that many people would envy what I did during the first week of my long awaited and much needed respite from my daily routine: I had a screening colonoscopy.
Yup, that’s right: a screening colonoscopy.
Want to read more...
An article published online yesterday in the American Cancer Society’s CA: A Journal for Clinicians which reviews in detail the relationship between health insurance (or lack thereof) and cancer outcomes has received a good deal of press attention over the past 24 hours.
The article, written by my colleagues from our Department of Epidemiology and Surveillance Research here at the Society, is an in-depth review of published research which correlates the presence or absence of adequate health insurance with access to cancer care, cancer screening, and cancer outcomes.
Want to read more...
The decision yesterday by the FDA’s Oncology Drug Advisory Committee to recommend that Avastin (bevacizumab) not be approved for the treatment of metastatic breast cancer is one more step in a discussion that has significant implications not only for the use of Avastin in breast cancer, but also how this type of decision-making is going to influence cancer treatment in the future.
Want to read more...
